Filing Details

Accession Number:
0000899243-19-025638
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-16 20:36:59
Reporting Period:
2019-10-14
Accepted Time:
2019-10-16 20:36:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1285819 Omeros Corp OMER Pharmaceutical Preparations (2834) 911663741
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472158 J. Thomas Cable C/O Omeros Corporation
201 Elliott Avenue West
Seattle WA 98119
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-10-14 5,000 $15.12 35,067 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person. The trading schedule, including sale periods and the number of shares to be sold, was determined at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The reporting person's Rule 10b5-1 trading plan further provides for the exercise and sale of up to 10,000 shares underlying outstanding stock options that will expire in December 2019 and 5,000 shares underlying stock options that will expire in May 2020.
  2. This transaction was executed in multiple trades at prices ranging from $14.64 to $15.44; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.